DCF — HIGHLANDS MEDICAL CENTER
Enterprise Value: $-40.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-40.6M
Enterprise Value
$-13.6M
PV of Cash Flows
$-27.0M
PV of Terminal Value
$-43.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $47.3M | $-2.1M | -5.0% | $-4.1M | $-3.8M |
| Year 2 | $48.7M | $-1.7M | -4.0% | $-3.8M | $-3.1M |
| Year 3 | $50.2M | $-1.3M | -3.0% | $-3.4M | $-2.5M |
| Year 4 | $51.7M | $-1.0M | -2.0% | $-3.2M | $-2.2M |
| Year 5 | $53.3M | $-0.9M | -2.0% | $-3.2M | $-2.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-40.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$45.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000217641507
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5